Viruses,
Journal Year:
2024,
Volume and Issue:
16(10), P. 1605 - 1605
Published: Oct. 12, 2024
Since
Mongolian
gerbils
are
broadly
susceptible
to
hepatitis
E
virus
(HEV),
including
genotypes
1,
4,
5,
and
8
(HEV-1,
HEV-5,
HEV-8)
rat
HEV,
they
a
useful
small
animal
model
for
HEV.
However,
we
have
observed
that
the
subtypes
HEV-3k
HEV-3ra
in
genotype
3
HEV
(HEV-3)
were
not
infected
efficiently
gerbils.
A
small-animal
HEV-3
is
also
needed
since
responsible
major
zoonotic
infections.
To
investigate
whether
can
be
used
as
models
other
of
HEV-3,
injected
with
five
(HEV-3b,
-3e,
-3f,
-3k,
-3ra)
compared
infectivity
subtypes.
We
detected
viral
RNA
gerbils'
feces.
High
titers
anti-HEV
IgG
antibodies
serum
induced
all
HEV-3b/ch-,
HEV-3f-,
HEV-3e-injected
Especially,
animals
released
high
levels
viruses
into
their
feces
an
extended
period.
The
replication
was
limited
HEV-3b/wb-injected
HEV-3k-injected
groups.
Although
HEV-3ra-injected
gerbils,
copy
numbers
fecal
specimens
low;
no
sera.
These
results
indicate
although
HEV-3's
depends
on
subtype
strain,
potential
HEV-3.
further
comparison
HEV-3e
different
strains
(HEV-4i
HEV-5)
genera
(rat
HEV)
revealed
ALT
elevations
among
strains,
liver
damage
occurred
HEV-4i-
HEV-5-infected
but
HEV-3e-
or
HEV-infected
demonstrating
variable
pathogenicity
across
HEVs
from
might
candidate
examine
HEV's
pathogenicity.
Environmental Toxicology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 4, 2025
ABSTRACT
Parabens
are
chemicals
used
as
preservatives
in
food,
personal
care
products,
and
pharmaceuticals.
Detectable
paraben
levels
found
water,
air,
soil,
making
human
animal
exposure
unavoidable.
This
study
evaluated
the
effects
of
methylparaben,
propylparaben,
their
mixture
on
prostate
gonads
male
female
gerbils.
Gerbils
aged
90
days
were
assigned
to
groups:
(M)
10
mg/kg/day
methylparaben;
(P)
propylparaben;
(M
+
P)
5
methylparaben
plus
(C)
control
group.
The
animals
treated
orally
for
30
consecutive
days,
prostates
subjected
morphometric‐stereological,
immunohistochemical,
biochemical
analyses.
ventral
P
M
groups
showed
an
increase
relative
weight,
higher
cell
proliferation,
besides
occurrence
hyperplasia
epithelial
desquamation.
All
treatments
reduced
malondialdehyde
prostate.
exhibited
alterations
all
groups,
but
with
greater
severity
groups.
These
included
increased
proliferation
hyperplasia,
well
stromal
inflammatory
foci
secretory
activity.
M,
P,
diameter
seminiferous
tubules,
thickness
germinal
epithelium,
catalase
activity
testes.
In
ovaries,
primary
follicle
number
superoxide
dismutase
results
indicate
that
propylparaben
is
more
harmful
than
acceptable
daily
intake
these
parabens
not
safe
reproductive
health.
We
previously
observed
a
notable
discrepancy
in
the
distribution
of
HEV-3
subtypes
between
wastewater
and
clinical
samples
Sweden.
To
confirm
this
observation
comprehensively
elucidate
circulation
patterns
across
humans,
animals,
environmental
waters
Sweden,
we
analyzed
HEV
genetic
diversity
archived
late
2016
early
2018,
cases
2012
2024,
all
available
Swedish
sequences
from
NCBI
Virus
database.
RNA
was
detected
samples,
with
subtype
3c
being
only
identified.
In
typed
cases,
3f
(45/126)
(44/126)
were
nearly
equally
distributed,
though
regional
dominance
varied.
When
incorporating
human
other
studies,
became
dominant
(75/168).
Analysis
revealed
that
(113/136)
Sus
scrofa
(pigs
wild
boars),
while
(30/33)
waters.
These
findings
highlight
complex
transmission
dynamics
The
near-absence
domestic
pigs
boars,
despite
its
high
proportion
raises
question
about
source
infection.
addition,
near-exclusive
detection
suggests
potential
differences
viral
shedding,
disease
severity
subtypes,
or
alternative
host
sources.
This
study
emphasizes
importance
integrated
One
Health
surveillance
to
track
reservoirs.
Antiviral Research,
Journal Year:
2024,
Volume and Issue:
227, P. 105922 - 105922
Published: May 31, 2024
Hepatitis
E
is
an
underestimated
disease,
leading
to
estimated
20
million
infections
and
up
70,000
deaths
annually.
Infections
are
mostly
asymptomatic,
but
can
reach
mortality
rates
25%
in
pregnant
women
or
become
chronic
immunocompromised
patients.
virus
(HEV)
infection
have
been
associated
with
a
range
of
extrahepatic
manifestations,
including
spectrum
neurological
symptoms.
Current
therapy
options
limited
non-specific
antivirals
like
ribavirin,
recently,
repurposed
viral
polymerase
inhibitors
sofosbuvir
NITD008
were
described
inhibit
HEV
replication.
Here,
we
evaluated
the
efficacy
these
drugs
various
neuronal-derived
cell
lines
determine
their
potency
outside
liver.
Our
findings
indicate
that
both
drugs,
especially
sofosbuvir,
exhibited
reduced
neuronal
cells
compared
hepatic
cells.
These
results
should
be
taken
into
account
development
direct-acting
for
at
replication
sites.
Zoonoses and Public Health,
Journal Year:
2024,
Volume and Issue:
unknown
Published: May 20, 2024
Hepatitis
E
caused
by
the
hepatitis
virus
(HEV)
is
prevalent
worldwide.
In
China,
considerable
shifts
in
epidemiology
of
have
been
observed
over
last
two
decades,
with
ongoing
changes
prevalence
HEV.
Hepatitis
E
virus
(HEV)
is
an
important
cause
of
acute
hepatitis,
however,
highly
neglected
and
largely
underreported.
This
study
aimed
to
describe
the
detailed
epidemiology
hepatitis
(HE)
through
a
10-year
surveillance.
A
community-based
active
surveillance
was
conducted
between
November
2007
October
2017
in
11
townships
Dongtai
City
China,
involving
355,673
residents.
Serum
samples
were
obtained
from
patients
presenting
with
symptoms
for
more
than
3
days.
alanine
aminotransferase
(ALT)
levels
greater
2.5
times
upper
limit
normal
(ULN)
considered
hepatitis.
Samples
subsequently
tested
IgG
IgM
anti-HEV
antibodies,
HEV
RNA,
B
surface
antigen
(HBsAg).
The
data
indicated
incidence
HE
fluctuated
downward
2017,
average
annual
age-standardized
17.50
per
100,000,
exceeding
10.26
100,000
National
Notifiable
Disease
Report
System
(NNDRS).
notably
higher
among
males
(20.95
100,000)
individuals
aged
50-69
years
(37.47
100,000).
Genotype
4
(HEV-4)
predominantly
circulating
genotype
during
period.
Furthermore,
revealed
(HBV)
co-infection
4.99
100,000.
system
identified
compared
NNDRS,
decreased
prevalence
over
While
efforts
are
still
needed
prevent
high-risk
populations,
including
elderly.
Journal of Virology,
Journal Year:
2024,
Volume and Issue:
98(7)
Published: July 23, 2024
ABSTRACT
Chronic
hepatitis
E
mostly
occurs
in
organ
transplant
recipients
and
can
lead
to
rapid
liver
fibrosis
cirrhosis.
Previous
studies
found
that
the
development
of
chronic
virus
(HEV)
infection
is
linked
type
immunosuppressant
used.
Animal
models
are
crucial
for
study
pathogenesis
E.
We
previously
established
a
stable
HEV
rabbit
model
using
cyclosporine
A
(CsA),
calcineurin
inhibitor
(CNI)-based
immunosuppressant.
However,
immunosuppression
strategy
timing
may
be
optimized,
how
different
types
immunosuppressants
affect
establishment
this
still
unknown.
Here,
we
showed
100%
rabbits
when
CsA
treatment
was
started
at
challenge
or
even
4
weeks
after.
Tacrolimus
prednisolone
alone
also
contributed
infection,
resulting
77.8%
chronicity
rates,
respectively,
while
mycophenolate
mofetil
(MMF)
only
led
28.6%
rate.
accompanied
with
persistent
activation
innate
immune
response
evidenced
by
transcriptome
analysis.
The
suppressed
adaptive
low
expression
genes
related
cytotoxicity
(like
perforin
FasL
)
anti-HEV
seroconversion
rates
play
important
roles
causing
infection.
By
analyzing
antigen
concentrations
outcomes,
levels
could
indicate
development.
This
optimized
strategies
establishing
highlighted
potential
association
between
immunosuppressants.
IMPORTANCE
Organ
high
risk
generally
receive
CNI-based
regimen
containing
CNI
(tacrolimus
CsA),
MMF,
and/or
corticosteroids.
Previously,
before
challenge.
In
study,
further
rabbits.
same
time
after
challenge,
clearly
indicating
progression
under
these
circumstances
necessity
screening
both
recipient
donor
preoperatively.
CsA,
tacrolimus,
instead
MMF
significantly
acute
phase
indicates
Our
results
have
implications
understanding
Journal of Medical Virology,
Journal Year:
2024,
Volume and Issue:
96(12)
Published: Dec. 1, 2024
ABSTRACT
Hepatitis
E
virus
(HEV)
poses
a
serious
threat
to
both
public
health
and
animal
food
safety,
thereby
highlighting
the
demands
for
rapid,
sensitive,
easy‐to‐use
detection.
This
study
aimed
develop
One‐Pot
assay
using
CRISPR/Cas13a
detecting
HEV
RNA,
suitable
point‐of‐care
testing
(POCT)
in
resource‐limited
settings.
combined
with
reverse
transcription
polymerase
chain
reaction
(RT‐PCR)
recombinase‐aided
amplification
(RT‐RAA)
was
applied
device.
Additionally,
large
cohort
of
HEV‐infected
patient
(154)
(104)
specimens
utilized
validation.
The
RT‐PCR/RT‐RAA
+
assays
RNA
detection
(genotypes:
HEV‐1,
HEV‐3,
HEV‐4)
were
established,
optimized,
validated,
achieving
limit
(LoD)
1
copy/μL
100%
specificity.
In
application
validation
infection,
positive
rates
RT‐PCR
CRISPR
RT‐RAA
98.6%
89.6%
patients,
96.6%
88.8%
animals,
respectively,
which
superior
those
RT‐qPCR.
Furthermore,
sample
rapid
lysis,
reagent
lyophilization,
device
integrated
construct
an
LoD
10
2
copies/μL.
Despite
slight
decreases
sensitivity,
significantly
reduces
time
35
min,
making
it
easy
perform,
minimizing
contamination,
meeting
requirements
screening.
We
developed
effectively
realizes
POCT
test
maximizes
impetus
implementation
shows
potential
as
valuable
tool
monitoring
infection.